Cell stimulation hPDLCs were seeded in 6-well plates and divided into the following two groups-the control group and Pg-LPS treatment group (LPS) to observe the key genes expressions. Besides, in order to explore whether KIAA0125 and CYP24A1 have a co-expression relationship in an in ammatory environment, hPDLCs were divided into four groups: Pg-LPS treatment group (LPS), 1,25-dihydroxyvitamin D3 (1,25D) (Sigma Aldrich, Saint Louis, MO, USA) and Pg-LPS treatment group (1,25D + LPS), 1,25D and Pg-LPS plus low concentrations of ketoconazole (MedChem Express, Monmouth Junction, USA) group (1,25D + LPS + 10 µM ketoconazole), and 1,25D and Pg-LPS plus high concentrations of ketoconazole group (1,25D + LPS + 100 µM ketoconazole). The concentration of Pg-LPS was 1 µg/mL and 1,25D was 10 nM. The incubation period was 24 hours.
Ketoconazole
Ketoconazole is a laboratory reagent commonly used as an antifungal agent. It functions as an inhibitor of the cytochrome P450 enzyme system, specifically targeting the CYP3A4 isoform. Ketoconazole is often utilized in various research applications that require the modulation of CYP3A4 activity.
Lab products found in correlation
9 protocols using ketoconazole
Exploring LPS-induced Cell Viability and Gene Expression in hPDLCs
Cell stimulation hPDLCs were seeded in 6-well plates and divided into the following two groups-the control group and Pg-LPS treatment group (LPS) to observe the key genes expressions. Besides, in order to explore whether KIAA0125 and CYP24A1 have a co-expression relationship in an in ammatory environment, hPDLCs were divided into four groups: Pg-LPS treatment group (LPS), 1,25-dihydroxyvitamin D3 (1,25D) (Sigma Aldrich, Saint Louis, MO, USA) and Pg-LPS treatment group (1,25D + LPS), 1,25D and Pg-LPS plus low concentrations of ketoconazole (MedChem Express, Monmouth Junction, USA) group (1,25D + LPS + 10 µM ketoconazole), and 1,25D and Pg-LPS plus high concentrations of ketoconazole group (1,25D + LPS + 100 µM ketoconazole). The concentration of Pg-LPS was 1 µg/mL and 1,25D was 10 nM. The incubation period was 24 hours.
Regulation of Cellular Signaling Pathways
Quantitative Analysis of Ibrutinib
Molecular Regulators of Lipid Metabolism
Investigating Aryl Hydrocarbon and Pregnane X Receptor Modulation
GC20 Purity Analysis by LC-MS/MS
Multimodal Cancer Therapy Protocol
In Vitro Evaluation of Venetoclax Interactions
Quantification of Ibrutinib and Metabolite in Plasma
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!